These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 35718751)

  • 1. Development of a traditional Chinese medicine-based agent for the treatment of cancer cachexia.
    Wu KC; Chu PC; Cheng YJ; Li CI; Tian J; Wu HY; Wu SH; Lai YC; Kao HH; Hsu AL; Lin HW; Lin CH
    J Cachexia Sarcopenia Muscle; 2022 Aug; 13(4):2073-2087. PubMed ID: 35718751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atractylenolide I ameliorates cancer cachexia through inhibiting biogenesis of IL-6 and tumour-derived extracellular vesicles.
    Fan M; Gu X; Zhang W; Shen Q; Zhang R; Fang Q; Wang Y; Guo X; Zhang X; Liu X
    J Cachexia Sarcopenia Muscle; 2022 Dec; 13(6):2724-2739. PubMed ID: 36085573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A standardized herbal combination of Astragalus membranaceus and Paeonia japonica, protects against muscle atrophy in a C26 colon cancer cachexia mouse model.
    Lee SB; Lee JS; Moon SO; Lee HD; Yoon YS; Son CG
    J Ethnopharmacol; 2021 Mar; 267():113470. PubMed ID: 33068652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cryptotanshinone prevents muscle wasting in CT26-induced cancer cachexia through inhibiting STAT3 signaling pathway.
    Chen L; Yang Q; Zhang H; Wan L; Xin B; Cao Y; Zhang J; Guo C
    J Ethnopharmacol; 2020 Oct; 260():113066. PubMed ID: 32505837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth of ovarian cancer xenografts causes loss of muscle and bone mass: a new model for the study of cancer cachexia.
    Pin F; Barreto R; Kitase Y; Mitra S; Erne CE; Novinger LJ; Zimmers TA; Couch ME; Bonewald LF; Bonetto A
    J Cachexia Sarcopenia Muscle; 2018 Aug; 9(4):685-700. PubMed ID: 30009406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Group I Paks support muscle regeneration and counteract cancer-associated muscle atrophy.
    Cerquone Perpetuini A; Re Cecconi AD; Chiappa M; Martinelli GB; Fuoco C; Desiderio G; Castagnoli L; Gargioli C; Piccirillo R; Cesareni G
    J Cachexia Sarcopenia Muscle; 2018 Aug; 9(4):727-746. PubMed ID: 29781585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Valproic acid attenuates skeletal muscle wasting by inhibiting C/EBPβ-regulated atrogin1 expression in cancer cachexia.
    Sun R; Zhang S; Hu W; Lu X; Lou N; Yang Z; Chen S; Zhang X; Yang H
    Am J Physiol Cell Physiol; 2016 Jul; 311(1):C101-15. PubMed ID: 27122162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carnosol and its analogues attenuate muscle atrophy and fat lipolysis induced by cancer cachexia.
    Lu S; Li Y; Shen Q; Zhang W; Gu X; Ma M; Li Y; Zhang L; Liu X; Zhang X
    J Cachexia Sarcopenia Muscle; 2021 Jun; 12(3):779-795. PubMed ID: 33951335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alantolactone ameliorates cancer cachexia-associated muscle atrophy mainly by inhibiting the STAT3 signaling pathway.
    Shen Q; Kuang JX; Miao CX; Zhang WL; Li YW; Zhang XW; Liu X
    Phytomedicine; 2022 Jan; 95():153858. PubMed ID: 34861585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Key Role for Leukemia Inhibitory Factor in C26 Cancer Cachexia.
    Seto DN; Kandarian SC; Jackman RW
    J Biol Chem; 2015 Aug; 290(32):19976-86. PubMed ID: 26092726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baicalin, a component of Scutellaria baicalensis, alleviates anorexia and inhibits skeletal muscle atrophy in experimental cancer cachexia.
    Li B; Wan L; Li Y; Yu Q; Chen P; Gan R; Yang Q; Han Y; Guo C
    Tumour Biol; 2014 Dec; 35(12):12415-25. PubMed ID: 25195133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Handelin alleviates cachexia- and aging-induced skeletal muscle atrophy by improving protein homeostasis and inhibiting inflammation.
    Zhang HJ; Wang BH; Wang X; Huang CP; Xu SM; Wang JL; Huang TE; Xiao WL; Tian XL; Lan XQ; Wang QQ; Xiang Y
    J Cachexia Sarcopenia Muscle; 2024 Feb; 15(1):173-188. PubMed ID: 38009816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular, cellular and physiological characterization of the cancer cachexia-inducing C26 colon carcinoma in mouse.
    Aulino P; Berardi E; Cardillo VM; Rizzuto E; Perniconi B; Ramina C; Padula F; Spugnini EP; Baldi A; Faiola F; Adamo S; Coletti D
    BMC Cancer; 2010 Jul; 10():363. PubMed ID: 20615237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Administration of adiponectin receptor agonist AdipoRon relieves cancer cachexia by mitigating inflammation in tumour-bearing mice.
    Massart IS; Kouakou AN; Pelet N; Lause P; Schakman O; Loumaye A; Abou-Samra M; Deldicque L; Bindels LB; Brichard SM; Thissen JP
    J Cachexia Sarcopenia Muscle; 2024 Jun; 15(3):919-933. PubMed ID: 38572511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IFIT2-depleted metastatic oral squamous cell carcinoma cells induce muscle atrophy and cancer cachexia in mice.
    Lai KC; Hong ZX; Hsieh JG; Lee HJ; Yang MH; Hsieh CH; Yang CH; Chen YR
    J Cachexia Sarcopenia Muscle; 2022 Apr; 13(2):1314-1328. PubMed ID: 35170238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Babao Dan Alleviates Cancer Cachexia in Mice Via Inhibiting IL-6/STAT3 Signaling Pathway.
    Qiu Z; Wo D; Zhong X; Chen J; Ma E; He J; Peng J; Zhu W; Ren DN
    Integr Cancer Ther; 2023; 22():15347354231168369. PubMed ID: 37077153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muscle-specific E3 ubiquitin ligases are involved in muscle atrophy of cancer cachexia: an in vitro and in vivo study.
    Yuan L; Han J; Meng Q; Xi Q; Zhuang Q; Jiang Y; Han Y; Zhang B; Fang J; Wu G
    Oncol Rep; 2015 May; 33(5):2261-8. PubMed ID: 25760630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-17A contributes to skeletal muscle atrophy in lung cancer-induced cachexia via JAK2/STAT3 pathway.
    Ying L; Yao Y; Lv H; Lu G; Zhang Q; Yang Y; Zhou J
    Am J Physiol Cell Physiol; 2022 May; 322(5):C814-C824. PubMed ID: 35319902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumour-derived leukaemia inhibitory factor is a major driver of cancer cachexia and morbidity in C26 tumour-bearing mice.
    Kandarian SC; Nosacka RL; Delitto AE; Judge AR; Judge SM; Ganey JD; Moreira JD; Jackman RW
    J Cachexia Sarcopenia Muscle; 2018 Dec; 9(6):1109-1120. PubMed ID: 30270531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IMB0901 inhibits muscle atrophy induced by cancer cachexia through MSTN signaling pathway.
    Liu D; Qiao X; Ge Z; Shang Y; Li Y; Wang W; Chen M; Si S; Chen SZ
    Skelet Muscle; 2019 Mar; 9(1):8. PubMed ID: 30922397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.